Skip to main content
Premium Trial:

Request an Annual Quote

EU Blueprint Effort to Fund Epigenetic Biomarker Projects

NEW YORK (GenomeWeb News) – The European Union plans to fund new research seeking to establish the clinical utility of epigenetic biomarkers for blood-based diseases under its Blueprint consortium program, a €30 million ($39.8 million) effort focused on advancing hematopoietic biomarkers.

The Blueprint program is supporting several projects to speed the development, validation, and use of epigenetic biomarkers in treating diseases such as myeloid and lymphoblastic leukemias, myelodysplastic syndromes, lymphomas, and type 1 diabetes.

So far, a software pipeline has been developed for bioinformatic analysis of large-scale DNA methylation datasets, a multi-center benchmarking study focused on DNA methylation has launched, and two discovery studies focused on candidate epigenetic biomarkers are ongoing. Now, the Blueprint program plans to fund efforts to validate epigenetic biomarkers that are based on well characterized cohorts from large randomized clinical trials, prospective cohort studies, and large-scale biobanking initiatives.

The ideal projects will lay out a "clear and consistent roadmap toward widespread clinical implementation," according to the Blueprint funding call, and will have preliminary data supporting the clinical relevance of the biomarkers they plan to use.

The Blueprint program provides funding for research projects as well as practical support with experimental assays and bioinformatic analysis of data.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.